Blood Glucose Monitoring Systems: Smart. Reliable. Accessible Diabetes Care.

India faces one of the world's largest diabetes epidemics, with over 77 million people affected.

SD BIOSENSOR offers a comprehensive blood glucose monitoring portfolio designed to support accurate and convenient diabetes management across home, professional, and healthcare settings.

Our portfolio brings together blood glucose meters, test strips, and essential accessories, with a focus on dependable performance, ease of use, and patient-friendly monitoring.

Key Portfolio Highlights

• Blood Glucose Monitoring Systems – Easy-to-use solutions for routine glucose testing( SD CodeFree, Standard GlucoNavii-GDH & Standard Mentor.)
• Blood Glucose Test Strips – Designed for convenient and reliable glucose measurement.
• Lancing & Sampling Solutions – Supporting safe and efficient blood sampling.
• Complete Monitoring Solutions – Meter, strips and accessories designed to work together for seamless diabetes management.

From a single glucose test to long-term diabetes management, SD BIOSENSOR is committed to making blood glucose monitoring simple, reliable and accessible.

STANDARD F: Next-Generation Fluorescent Immunoassay

STANDARD F from SD BIOSENSOR is a fluorescent immunoassay (FIA) platform designed to deliver accurate qualitative and quantitative diagnostic results across a broad range of clinical applications. The platform combines reliable performance, ease of operation and connectivity for efficient point-of-care and laboratory testing.

Comprehensive Diagnostic Portfolio

The STANDARD F portfolio supports testing across key clinical areas:

• Diabetes & Chronic Care: HbA1c, U-Albumin
• Infectious Diseases: CRP, Procalcitonin
• Cardiac & Cardiovascular: Troponin I, CK-MB, NT-proBNP, D-dimer, hs-CRP
• Other Clinical Applications: A broad menu of immunoassays supporting diverse diagnostic needs.

STANDARD F Analyzers

The platform includes STANDARD F200 and STANDARD F2400 analyzers, providing fluorescence-based testing with features such as touchscreen operation, built-in printing and LIS/HIS connectivity.

Why STANDARD F?

One Platform. Multiple Tests. Reliable Results.

STANDARD F helps healthcare professionals access quantitative diagnostic information quickly and efficiently, supporting clinical decision-making across chronic disease, infection and cardiovascular care.

SD BIOSENSOR — Advancing Diagnostics. Improving Healthcare.

Molecular Diagnostics: STANDARD M Platform

SD BIOSENSOR’s Molecular Point-of-Care Testing (POCT) solutions bring advanced nucleic-acid-based diagnostics closer to the patient, supporting fast, reliable and on-site detection of infectious diseases and drug-resistant pathogens. The company’s molecular diagnostics technology includes nucleic-acid extraction, amplification and cartridge-based POCT development.

Comprehensive Molecular Diagnostic Solutions

The STANDARD™ M10 platform provides an automated molecular testing solution with a growing menu covering important clinical applications, including:

• Respiratory infections – Flu, RSV and SARS-CoV-2
• Tuberculosis & drug resistance – MTB, MTB-RIF/INH and MDR-TB
• Sexually transmitted infections – CT/NG and STI panels
• HPV testing – HPV and high-risk HPV
• GI infections – C. difficile and other applications
• Vector-borne diseases – Dengue and other molecular panels
• Antimicrobial resistance – MRSA/SA and CARBA testing

Why Molecular POCT?

Molecular Accuracy. Automated Workflow. Results at the Point of Need.

By bringing molecular testing closer to patients, SD BIOSENSOR aims to support earlier diagnosis, timely clinical decisions and efficient infection management. Its molecular diagnostics R&D focuses on on-site diagnosis of infections and drug-resistant diseases.

SD BIOSENSOR — Advancing Molecular Diagnostics. Bringing Precision Closer to Patients.

Rapid Diagnostics Division:Fast. Simple. Reliable. Diagnostics at the Point of Need.

SD BIOSENSOR’s Rapid Diagnostics Division provides a broad portfolio of rapid diagnostic solutions designed to deliver timely results for screening, detection, monitoring and clinical decision-making across a wide range of healthcare applications.

Comprehensive Rapid Diagnostics Portfolio

Our rapid diagnostic portfolio includes:

• Infectious Disease Testing – Rapid tests for respiratory infections, gastrointestinal infections, tropical diseases and other infectious conditions.
• Cardiac & Cardiovascular Testing – Rapid detection and assessment of important cardiac markers.
• Women’s Health – Pregnancy and reproductive-health related rapid tests.
• Sexual Health – Rapid screening solutions for sexually transmitted infections.
• Gastrointestinal Testing – Rapid detection of gastrointestinal pathogens and related conditions.
• Drug & Substance Testing – Rapid screening solutions for drugs of abuse and related applications.

Point-of-Care Advantage

Designed for speed, simplicity and accessibility, SD BIOSENSOR rapid diagnostic tests enable testing closer to the patient and help healthcare professionals obtain actionable information without the need for complex laboratory infrastructure.

Why SD BIOSENSOR Rapid Diagnostics?

Broad Test Menu. Simple Workflow. Rapid Results.

From infectious disease screening to diabetes, cardiac, women’s health and other critical applications, SD BIOSENSOR continues to deliver innovative rapid diagnostic solutions that support early detection and better healthcare decisions.

SD BIOSENSOR — Fast & Accurate Diagnosis. Better Healthcare.

Hematology: ULTRA H300 from SD Biosensor— Accuracy. Efficiency. Confidence

A next-generation 3-Part Differential Hematology Analyzer delivering reliable results with streamlined operation and optimized running costs. Built for precision, designed for efficiency, and engineered for reliable results—bringing advanced hematology within easy reach of every laboratory.

Diagnostic Portfolio:

Combining intelligent technology, efficient workflow, and user-friendly operation, it provides an ideal solution for routine hematology testing.

Key Features

• 3-Part Differential Analysis – Reliable WBC (3 Part differential) with essential hematology parameters.
• High-Performance Testing – Designed for efficient routine laboratory operations.
• Fast & Reliable Results – Supports timely reporting and improved laboratory workflow.
• User-Friendly Operation – Interface for simple and efficient instrument handling.
• Compact & Space-Saving Design – Ideal for laboratories with limited bench space.
• Low Sample Volume – Helps optimize sample requirements, particularly for routine testing.
• Advanced Flagging & Alarms – Supports identification of abnormal results and potential sample abnormalities.
• Efficient Reagent Management – Designed for optimized reagent consumption and cost-effective operation.
• Reliable Performance – Built to provide consistent results for everyday diagnostic needs.
• Easy Maintenance – Simplified operation and maintenance help reduce downtime and support laboratory.

Built For Modern Diagnostics “Ultra H300”

ULTRA H300 brings together accuracy, efficiency, simplicity, and reliability—helping laboratories deliver dependable hematology results as part of a comprehensive diagnostic portfolio.

Why ULTRA H300?

Precision You Can Trust. Performance You Can Rely On.

ULTRA H300 combines advanced 3-Part Differential hematology technology with simple operation, efficient workflow, and dependable performance—making it a practical choice for modern diagnostic laboratories.

SD Biosensor:- “Ultra H300” Smarter Workflow. Reliable Results. Better Laboratory Performance.

ULTRA i:Advancing Diagnostic. Improving Healthcare.

ULTRA i from SD Biosensor is a benchtop chemiluminescence immunoassay (CLIA) platform engineered for superior analytical precision and versatile workflow efficiency. Available in dedicated 100 TPH and 200 TPH models, the system offers true random-access testing and ultra-sensitive quantification across diverse clinical panels—delivering dependable accuracy, fast turnaround times, and a compact laboratory footprint.

The ULTRA i portfolio supports comprehensive testing across high-demand clinical panels:

• Thyroid & Hormonal Function: TSH, FT3, FT4, Total T3, Total T4
• Fertility & Reproductive Health: AMH, ?-hCG, LH, FSH, Prolactin, Testosterone, Estradiol
• Cardiac & Critical Markers: High-Sensitivity Troponin I (hs-TnI), NT-proBNP, CK-MB
• Tumor Markers: PSA, Free PSA, CEA, AFP, CA 125, CA 19-9
• Infectious Disease & Inflammation: Procalcitonin (PCT)
• Bone Metabolism & Anemia: Vitamin D Total,  Vitamin B12, Folate, Ferritin

ULTRA iAnalyzers

The platform includes the ULTRA i1000 and ULTRA i2000 analyzers, offering flash-chemiluminescence technology with features such as continuous sample loading, automated onboard dilution, refrigerated reagent carousels, and bidirectional LIS/HIS connectivity.

Why ULTRA i

Superior Sensitivity. Broad Clinical Breadth. Uncompromising Precision.

ULTRA i enables clinical laboratories to deliver definitive diagnostic answers with short turnaround times and high dynamic range, empowering clinicians with confident decision-making across oncology, endocrinology, cardiology, and critical care management.

SD Biosensor— Advancing Diagnostic. Improving Healthcare.